Skip the main content if you do not want to read it as the next section.
Skip the location trail if you do not want to read it as the next section.
Location trail
HEALTH PROFESSIONALS > TREATMENT GUIDELINES > SPECIFIC CANCERS > OVARYUK treatment guidelines - Ovarian cancer
- Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for the treatment of advanced ovarian cancer, for relapsed disease only - NICE, 2005
- Review of the clinical effectiveness and cost effectiveness of paclitaxel for ovarian cancer - NICE, 2003
- Epithelial Ovarian Cancer: a national clinical guideline - SIGN - 2003
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for the treatment of advanced ovarian cancer, for relapsed disease only - NICE, 2005
Produced by: National Institute for Health and Clinical Excellence (NICE), July 2002. Technology Appraisal No.45.
Purpose: This guidance issued by NICE only applies to the use of paclitaxel, PLDH and topotecan for the treatment of women with advanced ovarian cancer.
Can be obtained from: The NICE website.
Link to website: http://guidance.nice.org.uk/TA91/?c=91496
Review of the clinical effectiveness and cost effectiveness of paclitaxel for ovarian cancer - NICE, 2003
Produced by: National Institute for Health and Clinical Excellence (NICE) - January 2003 (Review) Technology Appraisal No.55
Purpose: Guidance on the use of the use of paclitaxel in the treatment of ovarian cancer.
Can be obtained from: The NICE website.
Link to website: http://guidance.nice.org.uk/TA55/?c=91496
Epithelial Ovarian Cancer: a national clinical guideline - SIGN - 2003
Produced by: Scottish Intercollegiate Guidelines Network, SIGN, October 2003
Purpose: This guideline is concerned with epithelial ovarian cancer only. The guideline also highlights areas of controversy as well as recommending good practice where evidence exists.
Can be obtained from: The SIGN website.
Link to website: www.sign.ac.uk/guidelines/fulltext/75
Content last reviewed: 01 July 2007
Page last modified: 11 September 2007
Page last modified: 11 September 2007